SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energys sharp rally is being linked by traders to Oracle reaffirming its Project Jupiter fuel-cell commitment and the broader AI data-center power-demand story; some also cite S&P 500 rebalancing. The move has prompted profit-taking and short-covering speculation, while skeptics point to the stocks high valuation and volatility.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, citing stronger demand for Amtagvi and Proleukin, is driving the sharp move and bullish reaction. Traders are also looking ahead to lung-cancer data and analyst upgrades, while short-squeeze and takeover talk remains speculative.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results beat expectations, while record bookings and a stronger full-year outlook fueled a sharp rally and bullish reactions. Some traders remain cautious about higher fuel costs and weaker near-term guidance.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFA moves to include VantageScore alongside FICO in mortgage scoring have intensified concerns that FICOs longstanding advantage in the mortgage market will erode and face pricing pressure. Traders are divided between viewing the selloff as an overreaction and buying opportunity, and expecting competition to weaken FICOs moat and weigh on its business.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles rebound is being linked by traders to reports of OpenAI revenue growth and continued AI-cloud demand, with some also citing short-covering after Michael Burry disclosed closing his Oracle short. Bulls frame the move as a squeeze or oversold bounce, while skeptics question its staying power amid debt and Project Jupiter execution concerns.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation silicon-carbide power semiconductors is driving attention, with traders viewing the award as technology validation and a possible defense-market opportunity. The reaction is mixed after a sharp, volatile move: bulls emphasize the strategic endorsement, while skeptics note that the award is a prototype effort with undisclosed financial terms and no clear near-term revenue impact.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas $2 billion convertible-equity investment and clinical collaboration on ivonescimab are driving attention, with traders citing added funding and major-pharma validation while debating dilution and emphasizing that the deal is not a buyout. Some see it as supportive ahead of the separate FDA decision, but approval remains uncertain.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as Treasury yields climb and traders weigh persistent inflation and the possibility of further Fed tightening. The community is split between expecting more losses in long-duration bonds and viewing the selloff as oversold with a potential rebound ahead.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentums strong results and upbeat outlook, along with rising AI data-center demand for optical connectivity, are fueling attention across photonics stocks. Traders are leaning bullish on the growth story and a potential technical breakout, while others warn that rich valuation and sharp volatility leave the shares vulnerable to profit-taking.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp rally and perceived resistance break have sparked momentum chatter, with traders speculating that a Robinhood connection or new Zebec utility may be behind the move; neither is confirmed in the discussion. Bulls expect the advance to continue, while skeptics warn it could be another short-lived pump.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Imagine buying $GRTS at its peak, only to watch it crash like this  and then finding out there’s a way to get some money back. 
 
To all $GRTS investors out there, we’ve got some important news: a $6 million investor settlement is now open for claims from shareholders who purchased shares between 2023 and 2024.  
 
You can check if you’re eligible and claim your share: https://11th.com/cases/gritstone-investor-settlement

Gritstone bio has reached a tentative settlement to resolve investor claims that it misled the market about the timing of its CORAL Phase 2b study, related B...

11th.com

Gritstone bio ($GRTS) Investor Settlement

StockTwits Web

Gritstone Bio Inc

 at its peak, only to watch it crash like this  and then finding out there’s a way to get some money back. 
 
To all 

 investors out there, we’ve got some important news: a $6 million investor settlement is now open for claims from shareholders who purchased shares between 2023 and 2024.  
 
You can check if you’re eligible and claim your share: 